A Wayne State University School of Medicine faculty member has been awarded a total of $2.3 million by the National Institute ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Oct. 24, 2024 — Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes ... Oct. 17, 2024 — Symptoms and disease progression of Rett ...

RAND focused its model on four chronic conditions — cardiovascular disease, asthma, end-stage kidney disease and Alzheimer’s ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

The annual Walk to End Alzheimer's will take place on Saturday ... She said that festivities will begin at 8:30 a.m., with an ...

Some of the most well known signs of dementia include memory loss, difficulty concentrating and struggling to follow a ...

The annual Walk to End Alzheimer’s raises funds for research and provides support to families affected by Alzheimer’s and ...

The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.

Alzheimer’s is a brain disease that currently has no cure. But the Alzheimer’s Association is doing all they can to raise ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...